COVID-19 Impact on Global Gene Therapies for Tumor Treatment Market Insights, Forecast to 2026
Gene Therapies for Tumor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapies for Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gene Therapies for Tumor Treatment market is segmented into
The Gene Therapies for Tumor Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gene Therapies for Tumor Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gene Therapies for Tumor Treatment Market Share Analysis
Gene Therapies for Tumor Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gene Therapies for Tumor Treatment business, the date to enter into the Gene Therapies for Tumor Treatment market, Gene Therapies for Tumor Treatment product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Gene Therapies for Tumor Treatment market is segmented into
- Gene Induced Immunotherapy
- Oncolytic Virotherapy
- Gene Transfer
- Hospital
- Clinic
- Other
The Gene Therapies for Tumor Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gene Therapies for Tumor Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gene Therapies for Tumor Treatment Market Share Analysis
Gene Therapies for Tumor Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gene Therapies for Tumor Treatment business, the date to enter into the Gene Therapies for Tumor Treatment market, Gene Therapies for Tumor Treatment product introduction, recent developments, etc.
The major vendors covered:
- Novartis
- Kite Pharma
- Amgen
- Shanghai Sunway
- Sibiono
- ...
1 STUDY COVERAGE
1.1 Gene Therapies for Tumor Treatment Product Introduction
1.2 Market Segments
1.3 Key Gene Therapies for Tumor Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type
1.4.2 Gene Induced Immunotherapy
1.4.3 Oncolytic Virotherapy
1.4.4 Gene Transfer
1.5 Market by Application
1.5.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Tumor Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapies for Tumor Treatment Industry
1.6.1.1 Gene Therapies for Tumor Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapies for Tumor Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapies for Tumor Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Gene Therapies for Tumor Treatment Market Size Estimates and Forecasts
2.1.1 Global Gene Therapies for Tumor Treatment Revenue 2015-2026
2.1.2 Global Gene Therapies for Tumor Treatment Sales 2015-2026
2.2 Gene Therapies for Tumor Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL GENE THERAPIES FOR TUMOR TREATMENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Gene Therapies for Tumor Treatment Sales by Manufacturers
3.1.1 Gene Therapies for Tumor Treatment Sales by Manufacturers (2015-2020)
3.1.2 Gene Therapies for Tumor Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Gene Therapies for Tumor Treatment Revenue by Manufacturers
3.2.1 Gene Therapies for Tumor Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Gene Therapies for Tumor Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2019
3.2.5 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gene Therapies for Tumor Treatment Price by Manufacturers
3.4 Gene Therapies for Tumor Treatment Manufacturing Base Distribution, Product Types
3.4.1 Gene Therapies for Tumor Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gene Therapies for Tumor Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Gene Therapies for Tumor Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapies for Tumor Treatment Market Size by Type (2015-2020)
4.1.1 Global Gene Therapies for Tumor Treatment Sales by Type (2015-2020)
4.1.2 Global Gene Therapies for Tumor Treatment Revenue by Type (2015-2020)
4.1.3 Gene Therapies for Tumor Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gene Therapies for Tumor Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Gene Therapies for Tumor Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gene Therapies for Tumor Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapies for Tumor Treatment Market Size by Application (2015-2020)
5.1.1 Global Gene Therapies for Tumor Treatment Sales by Application (2015-2020)
5.1.2 Global Gene Therapies for Tumor Treatment Revenue by Application (2015-2020)
5.1.3 Gene Therapies for Tumor Treatment Price by Application (2015-2020)
5.2 Gene Therapies for Tumor Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Gene Therapies for Tumor Treatment Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapies for Tumor Treatment by Country
6.1.1 North America Gene Therapies for Tumor Treatment Sales by Country
6.1.2 North America Gene Therapies for Tumor Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gene Therapies for Tumor Treatment Market Facts & Figures by Type
6.3 North America Gene Therapies for Tumor Treatment Market Facts & Figures by Application
7 EUROPE
7.1 Europe Gene Therapies for Tumor Treatment by Country
7.1.1 Europe Gene Therapies for Tumor Treatment Sales by Country
7.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gene Therapies for Tumor Treatment Market Facts & Figures by Type
7.3 Europe Gene Therapies for Tumor Treatment Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Gene Therapies for Tumor Treatment by Region
8.1.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region
8.1.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gene Therapies for Tumor Treatment Market Facts & Figures by Type
8.3 Asia Pacific Gene Therapies for Tumor Treatment Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Gene Therapies for Tumor Treatment by Country
9.1.1 Latin America Gene Therapies for Tumor Treatment Sales by Country
9.1.2 Latin America Gene Therapies for Tumor Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gene Therapies for Tumor Treatment Market Facts & Figures by Type
9.3 Central & South America Gene Therapies for Tumor Treatment Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Gene Therapies for Tumor Treatment by Country
10.1.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country
10.1.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gene Therapies for Tumor Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Gene Therapies for Tumor Treatment Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
11.1.5 Novartis Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Corporation Information
11.2.2 Kite Pharma Description, Business Overview and Total Revenue
11.2.3 Kite Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Kite Pharma Gene Therapies for Tumor Treatment Products Offered
11.2.5 Kite Pharma Recent Development
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description, Business Overview and Total Revenue
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Gene Therapies for Tumor Treatment Products Offered
11.3.5 Amgen Recent Development
11.4 Shanghai Sunway
11.4.1 Shanghai Sunway Corporation Information
11.4.2 Shanghai Sunway Description, Business Overview and Total Revenue
11.4.3 Shanghai Sunway Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Products Offered
11.4.5 Shanghai Sunway Recent Development
11.5 Sibiono
11.5.1 Sibiono Corporation Information
11.5.2 Sibiono Description, Business Overview and Total Revenue
11.5.3 Sibiono Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sibiono Gene Therapies for Tumor Treatment Products Offered
11.5.5 Sibiono Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Gene Therapies for Tumor Treatment Market Estimates and Projections by Region
12.1.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.2.2 North America: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gene Therapies for Tumor Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gene Therapies for Tumor Treatment Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Gene Therapies for Tumor Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Gene Therapies for Tumor Treatment Product Introduction
1.2 Market Segments
1.3 Key Gene Therapies for Tumor Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type
1.4.2 Gene Induced Immunotherapy
1.4.3 Oncolytic Virotherapy
1.4.4 Gene Transfer
1.5 Market by Application
1.5.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Tumor Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapies for Tumor Treatment Industry
1.6.1.1 Gene Therapies for Tumor Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapies for Tumor Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapies for Tumor Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Gene Therapies for Tumor Treatment Market Size Estimates and Forecasts
2.1.1 Global Gene Therapies for Tumor Treatment Revenue 2015-2026
2.1.2 Global Gene Therapies for Tumor Treatment Sales 2015-2026
2.2 Gene Therapies for Tumor Treatment Market Size by Region: 2020 Versus 2026
2.2.1 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL GENE THERAPIES FOR TUMOR TREATMENT COMPETITOR LANDSCAPE BY PLAYERS
3.1 Gene Therapies for Tumor Treatment Sales by Manufacturers
3.1.1 Gene Therapies for Tumor Treatment Sales by Manufacturers (2015-2020)
3.1.2 Gene Therapies for Tumor Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Gene Therapies for Tumor Treatment Revenue by Manufacturers
3.2.1 Gene Therapies for Tumor Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Gene Therapies for Tumor Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2019
3.2.5 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gene Therapies for Tumor Treatment Price by Manufacturers
3.4 Gene Therapies for Tumor Treatment Manufacturing Base Distribution, Product Types
3.4.1 Gene Therapies for Tumor Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gene Therapies for Tumor Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Gene Therapies for Tumor Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapies for Tumor Treatment Market Size by Type (2015-2020)
4.1.1 Global Gene Therapies for Tumor Treatment Sales by Type (2015-2020)
4.1.2 Global Gene Therapies for Tumor Treatment Revenue by Type (2015-2020)
4.1.3 Gene Therapies for Tumor Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gene Therapies for Tumor Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Gene Therapies for Tumor Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gene Therapies for Tumor Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapies for Tumor Treatment Market Size by Application (2015-2020)
5.1.1 Global Gene Therapies for Tumor Treatment Sales by Application (2015-2020)
5.1.2 Global Gene Therapies for Tumor Treatment Revenue by Application (2015-2020)
5.1.3 Gene Therapies for Tumor Treatment Price by Application (2015-2020)
5.2 Gene Therapies for Tumor Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Gene Therapies for Tumor Treatment Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapies for Tumor Treatment by Country
6.1.1 North America Gene Therapies for Tumor Treatment Sales by Country
6.1.2 North America Gene Therapies for Tumor Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gene Therapies for Tumor Treatment Market Facts & Figures by Type
6.3 North America Gene Therapies for Tumor Treatment Market Facts & Figures by Application
7 EUROPE
7.1 Europe Gene Therapies for Tumor Treatment by Country
7.1.1 Europe Gene Therapies for Tumor Treatment Sales by Country
7.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gene Therapies for Tumor Treatment Market Facts & Figures by Type
7.3 Europe Gene Therapies for Tumor Treatment Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Gene Therapies for Tumor Treatment by Region
8.1.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region
8.1.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gene Therapies for Tumor Treatment Market Facts & Figures by Type
8.3 Asia Pacific Gene Therapies for Tumor Treatment Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Gene Therapies for Tumor Treatment by Country
9.1.1 Latin America Gene Therapies for Tumor Treatment Sales by Country
9.1.2 Latin America Gene Therapies for Tumor Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gene Therapies for Tumor Treatment Market Facts & Figures by Type
9.3 Central & South America Gene Therapies for Tumor Treatment Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Gene Therapies for Tumor Treatment by Country
10.1.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country
10.1.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gene Therapies for Tumor Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Gene Therapies for Tumor Treatment Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
11.1.5 Novartis Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Corporation Information
11.2.2 Kite Pharma Description, Business Overview and Total Revenue
11.2.3 Kite Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Kite Pharma Gene Therapies for Tumor Treatment Products Offered
11.2.5 Kite Pharma Recent Development
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description, Business Overview and Total Revenue
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Gene Therapies for Tumor Treatment Products Offered
11.3.5 Amgen Recent Development
11.4 Shanghai Sunway
11.4.1 Shanghai Sunway Corporation Information
11.4.2 Shanghai Sunway Description, Business Overview and Total Revenue
11.4.3 Shanghai Sunway Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Products Offered
11.4.5 Shanghai Sunway Recent Development
11.5 Sibiono
11.5.1 Sibiono Corporation Information
11.5.2 Sibiono Description, Business Overview and Total Revenue
11.5.3 Sibiono Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sibiono Gene Therapies for Tumor Treatment Products Offered
11.5.5 Sibiono Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Gene Therapies for Tumor Treatment Market Estimates and Projections by Region
12.1.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.2.2 North America: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gene Therapies for Tumor Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gene Therapies for Tumor Treatment Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Gene Therapies for Tumor Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Gene Therapies for Tumor Treatment Market Segments
Table 2. Ranking of Global Top Gene Therapies for Tumor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Gene Induced Immunotherapy
Table 5. Major Manufacturers of Oncolytic Virotherapy
Table 6. Major Manufacturers of Gene Transfer
Table 7. COVID-19 Impact Global Market: (Four Gene Therapies for Tumor Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapies for Tumor Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapies for Tumor Treatment Players to Combat Covid-19 Impact
Table 12. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Gene Therapies for Tumor Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapies for Tumor Treatment Sales by Regions 2015-2020 (K Units)
Table 15. Global Gene Therapies for Tumor Treatment Sales Market Share by Regions (2015-2020)
Table 16. Global Gene Therapies for Tumor Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Gene Therapies for Tumor Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Gene Therapies for Tumor Treatment Sales Share by Manufacturers (2015-2020)
Table 19. Global Gene Therapies for Tumor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Gene Therapies for Tumor Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Tumor Treatment as of 2019)
Table 21. Gene Therapies for Tumor Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Gene Therapies for Tumor Treatment Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Gene Therapies for Tumor Treatment Price (2015-2020) (USD/Unit)
Table 24. Gene Therapies for Tumor Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Gene Therapies for Tumor Treatment Product Type
Table 26. Date of International Manufacturers Enter into Gene Therapies for Tumor Treatment Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 29. Global Gene Therapies for Tumor Treatment Sales Share by Type (2015-2020)
Table 30. Global Gene Therapies for Tumor Treatment Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Gene Therapies for Tumor Treatment Revenue Share by Type (2015-2020)
Table 32. Gene Therapies for Tumor Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 34. Global Gene Therapies for Tumor Treatment Sales Share by Application (2015-2020)
Table 35. North America Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 36. North America Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 37. North America Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 39. North America Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 40. North America Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 41. North America Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 42. North America Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 43. Europe Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 44. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 45. Europe Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 47. Europe Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 48. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 49. Europe Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 50. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Gene Therapies for Tumor Treatment Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 59. Latin America Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 60. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 63. Latin America Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 64. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 65. Latin America Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 66. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Kite Pharma Corporation Information
Table 81. Kite Pharma Description and Major Businesses
Table 82. Kite Pharma Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Kite Pharma Product
Table 84. Kite Pharma Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Major Businesses
Table 87. Amgen Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Amgen Product
Table 89. Amgen Recent Development
Table 90. Shanghai Sunway Corporation Information
Table 91. Shanghai Sunway Description and Major Businesses
Table 92. Shanghai Sunway Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Shanghai Sunway Product
Table 94. Shanghai Sunway Recent Development
Table 95. Sibiono Corporation Information
Table 96. Sibiono Description and Major Businesses
Table 97. Sibiono Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sibiono Product
Table 99. Sibiono Recent Development
Table 100. Global Gene Therapies for Tumor Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 101. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Gene Therapies for Tumor Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 105. North America: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 107. Europe: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Gene Therapies for Tumor Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 109. Asia Pacific: Gene Therapies for Tumor Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 111. Latin America: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 113. Middle East and Africa: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Gene Therapies for Tumor Treatment Players
Table 118. Gene Therapies for Tumor Treatment Customers List
Table 119. Gene Therapies for Tumor Treatment Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 1. Gene Therapies for Tumor Treatment Market Segments
Table 2. Ranking of Global Top Gene Therapies for Tumor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Gene Induced Immunotherapy
Table 5. Major Manufacturers of Oncolytic Virotherapy
Table 6. Major Manufacturers of Gene Transfer
Table 7. COVID-19 Impact Global Market: (Four Gene Therapies for Tumor Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapies for Tumor Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapies for Tumor Treatment Players to Combat Covid-19 Impact
Table 12. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Gene Therapies for Tumor Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapies for Tumor Treatment Sales by Regions 2015-2020 (K Units)
Table 15. Global Gene Therapies for Tumor Treatment Sales Market Share by Regions (2015-2020)
Table 16. Global Gene Therapies for Tumor Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Gene Therapies for Tumor Treatment Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Gene Therapies for Tumor Treatment Sales Share by Manufacturers (2015-2020)
Table 19. Global Gene Therapies for Tumor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Gene Therapies for Tumor Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Tumor Treatment as of 2019)
Table 21. Gene Therapies for Tumor Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Gene Therapies for Tumor Treatment Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Gene Therapies for Tumor Treatment Price (2015-2020) (USD/Unit)
Table 24. Gene Therapies for Tumor Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Gene Therapies for Tumor Treatment Product Type
Table 26. Date of International Manufacturers Enter into Gene Therapies for Tumor Treatment Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 29. Global Gene Therapies for Tumor Treatment Sales Share by Type (2015-2020)
Table 30. Global Gene Therapies for Tumor Treatment Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Gene Therapies for Tumor Treatment Revenue Share by Type (2015-2020)
Table 32. Gene Therapies for Tumor Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 34. Global Gene Therapies for Tumor Treatment Sales Share by Application (2015-2020)
Table 35. North America Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 36. North America Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 37. North America Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 39. North America Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 40. North America Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 41. North America Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 42. North America Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 43. Europe Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 44. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 45. Europe Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 47. Europe Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 48. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 49. Europe Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 50. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Gene Therapies for Tumor Treatment Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 59. Latin America Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 60. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 63. Latin America Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 64. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 65. Latin America Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 66. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Gene Therapies for Tumor Treatment Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Kite Pharma Corporation Information
Table 81. Kite Pharma Description and Major Businesses
Table 82. Kite Pharma Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Kite Pharma Product
Table 84. Kite Pharma Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Major Businesses
Table 87. Amgen Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Amgen Product
Table 89. Amgen Recent Development
Table 90. Shanghai Sunway Corporation Information
Table 91. Shanghai Sunway Description and Major Businesses
Table 92. Shanghai Sunway Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Shanghai Sunway Product
Table 94. Shanghai Sunway Recent Development
Table 95. Sibiono Corporation Information
Table 96. Sibiono Description and Major Businesses
Table 97. Sibiono Gene Therapies for Tumor Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sibiono Product
Table 99. Sibiono Recent Development
Table 100. Global Gene Therapies for Tumor Treatment Sales Forecast by Regions (2021-2026) (K Units)
Table 101. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Gene Therapies for Tumor Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 105. North America: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 107. Europe: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Gene Therapies for Tumor Treatment Sales Forecast by Region (2021-2026) (K Units)
Table 109. Asia Pacific: Gene Therapies for Tumor Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 111. Latin America: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Gene Therapies for Tumor Treatment Sales Forecast by Country (2021-2026) (K Units)
Table 113. Middle East and Africa: Gene Therapies for Tumor Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Gene Therapies for Tumor Treatment Players
Table 118. Gene Therapies for Tumor Treatment Customers List
Table 119. Gene Therapies for Tumor Treatment Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Gene Therapies for Tumor Treatment Product Picture
Figure 2. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Gene Induced Immunotherapy Product Picture
Figure 4. Oncolytic Virotherapy Product Picture
Figure 5. Gene Transfer Product Picture
Figure 6. Global Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Gene Therapies for Tumor Treatment Report Years Considered
Figure 11. Global Gene Therapies for Tumor Treatment Market Size 2015-2026 (US$ Million)
Figure 12. Global Gene Therapies for Tumor Treatment Sales 2015-2026 (K Units)
Figure 13. Global Gene Therapies for Tumor Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2015-2020)
Figure 15. Global Gene Therapies for Tumor Treatment Sales Market Share by Region in 2019
Figure 16. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2015-2020)
Figure 17. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region in 2019
Figure 18. Global Gene Therapies for Tumor Treatment Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Gene Therapies for Tumor Treatment Revenue in 2019
Figure 20. Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Figure 22. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2019
Figure 23. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2015-2020)
Figure 24. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type in 2019
Figure 25. Global Gene Therapies for Tumor Treatment Market Share by Price Range (2015-2020)
Figure 26. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Figure 27. Global Gene Therapies for Tumor Treatment Sales Market Share by Application in 2019
Figure 28. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2015-2020)
Figure 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application in 2019
Figure 30. North America Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 33. North America Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 34. U.S. Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 39. North America Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 40. Europe Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 43. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 44. Germany Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 55. Europe Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 56. Asia Pacific Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Region in 2019
Figure 59. Asia Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Region in 2019
Figure 60. China Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 83. Asia Pacific Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 84. Latin America Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 87. Latin America Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 88. Mexico Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 95. Latin America Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 96. Middle East and Africa Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 100. Turkey Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 107. Middle East and Africa Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shanghai Sunway Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sibiono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Gene Therapies for Tumor Treatment Product Picture
Figure 2. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Gene Induced Immunotherapy Product Picture
Figure 4. Oncolytic Virotherapy Product Picture
Figure 5. Gene Transfer Product Picture
Figure 6. Global Gene Therapies for Tumor Treatment Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Gene Therapies for Tumor Treatment Report Years Considered
Figure 11. Global Gene Therapies for Tumor Treatment Market Size 2015-2026 (US$ Million)
Figure 12. Global Gene Therapies for Tumor Treatment Sales 2015-2026 (K Units)
Figure 13. Global Gene Therapies for Tumor Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Gene Therapies for Tumor Treatment Sales Market Share by Region (2015-2020)
Figure 15. Global Gene Therapies for Tumor Treatment Sales Market Share by Region in 2019
Figure 16. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2015-2020)
Figure 17. Global Gene Therapies for Tumor Treatment Revenue Market Share by Region in 2019
Figure 18. Global Gene Therapies for Tumor Treatment Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Gene Therapies for Tumor Treatment Revenue in 2019
Figure 20. Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2015-2020)
Figure 22. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2019
Figure 23. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2015-2020)
Figure 24. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type in 2019
Figure 25. Global Gene Therapies for Tumor Treatment Market Share by Price Range (2015-2020)
Figure 26. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2015-2020)
Figure 27. Global Gene Therapies for Tumor Treatment Sales Market Share by Application in 2019
Figure 28. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2015-2020)
Figure 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application in 2019
Figure 30. North America Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 33. North America Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 34. U.S. Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 39. North America Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 40. Europe Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 43. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 44. Germany Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 55. Europe Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 56. Asia Pacific Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Gene Therapies for Tumor Treatment Sales Market Share by Region in 2019
Figure 59. Asia Pacific Gene Therapies for Tumor Treatment Revenue Market Share by Region in 2019
Figure 60. China Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 83. Asia Pacific Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 84. Latin America Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 87. Latin America Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 88. Mexico Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 95. Latin America Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 96. Middle East and Africa Gene Therapies for Tumor Treatment Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Gene Therapies for Tumor Treatment Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2019
Figure 100. Turkey Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Gene Therapies for Tumor Treatment Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Gene Therapies for Tumor Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Gene Therapies for Tumor Treatment Market Share by Type in 2019
Figure 107. Middle East and Africa Gene Therapies for Tumor Treatment Market Share by Application in 2019
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Shanghai Sunway Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sibiono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Gene Therapies for Tumor Treatment Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Gene Therapies for Tumor Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
